Age-related differences in anxiety-like behavior and amygdalar CCL2 responsiveness to stress following alcohol withdrawal in male Wistar rats.
Behavioral and neuroimmune vulnerability to withdrawal from chronic alcohol varies with age. The relation of anxiety-like behavior to amygdalar CCL2 responses following stress after withdrawal from chronic intermittent alcohol (CIA) was investigated in adolescent and adult rats.



Adolescent and adult Wistar rats were exposed to CIA (three 5-day blocks of dietary alcohol separated by 2 days of withdrawal) at concentrations that created similar blood alcohol levels across age. Twenty-four hours into the final withdrawal, half of the rats were exposed to 1 h of restraint stress. Four hours post-stress, rats were used for behavior or tissue assays.



Anxiety-like behavior was increased versus controls by CIA in adolescents and by CIA + stress in adults. CCL2 mRNA was increased versus controls by CIA in adolescents and by CIA and CIA + stress in adults. CCL2 co-localization with neuronal marker NeuN was decreased versus controls by CIA in adolescents and by CIA + stress in adults. CCL2 co-localization with astrocytic marker GFAP was decreased versus controls by CIA and CIA + stress in adolescents, but experimental groups did not differ from controls in adults. CCL2 co-localization with microglial marker Iba1 was decreased versus controls by stress alone in adolescents and by CIA + stress in adults.



Changes in CCL2 protein might control behavior at either age but are particularly associated with CIA alone in adolescents and with CIA + stress in adults. That the number of CeA neurons expressing CCL2 was altered after CIA and stress is consistent with CCL2 involvement in neural function.
Bowles Center for Alcohol Studies, The University of North Carolina at Chapel Hill, School of Medicine, CB#7178, 3006 Thurston-Bowles Building, Chapel Hill, NC, 27599-7178, USA.
Kathryn M
KM
Harper
Bowles Center for Alcohol Studies, The University of North Carolina at Chapel Hill, School of Medicine, CB#7178, 3006 Thurston-Bowles Building, Chapel Hill, NC, 27599-7178, USA. darin_knapp@med.unc.edu.|Department of Psychiatry, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. darin_knapp@med.unc.edu.
Darin J
DJ
Knapp
Bowles Center for Alcohol Studies, The University of North Carolina at Chapel Hill, School of Medicine, CB#7178, 3006 Thurston-Bowles Building, Chapel Hill, NC, 27599-7178, USA.
Meredith A
MA
Park
Bowles Center for Alcohol Studies, The University of North Carolina at Chapel Hill, School of Medicine, CB#7178, 3006 Thurston-Bowles Building, Chapel Hill, NC, 27599-7178, USA.|Department of Psychiatry, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.|Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.|Curriculum in Neurobiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.|The UNC Neuroscience Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
George R
GR
Breese
D000679:Amygdala / Q000378:metabolism*; D000818:Animals; D001007:Anxiety / Q000139:chemically induced / Q000378:metabolism*; D001522:Behavior, Animal / Q000502:physiology*; D018932:Chemokine CCL2 / Q000378:metabolism*; D000431:Ethanol / Q000009:adverse effects*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D017208:Rats, Wistar; D013375:Substance Withdrawal Syndrome / Q000378:metabolism*
C491766:Ccl2 protein, rat; D018932:Chemokine CCL2; D000431:Ethanol
Adolescent; Adult; Astrocytes; Ethanol; Microglia; Neurons
Alcohol Clin Exp Res. 2007 Nov;31(11):1872-82
17908266
Alcohol Clin Exp Res. 2016 Jan;40(1):187-95
26683974
Front Integr Neurosci. 2014 Apr 04;8:29
24772072
Alcohol Clin Exp Res. 2014 Feb;38(2):384-91
24033454
J Comp Neurol. 2005 Nov 14;492(2):178-92
16196033
J Neuroinflammation. 2012 May 24;9:97
22626265
J Neurochem. 2010 Apr;113(2):543-51
20132473
Behav Brain Res. 2005 Nov 30;165(1):110-25
16105698
J Pharmacol Exp Ther. 1983 Dec;227(3):663-70
6317842
Alcohol Clin Exp Res. 2009 Mar;33(3):455-63
19120055
Alcohol Clin Exp Res. 2010 Sep 1;34(9):1603-12
20586753
Int J Dev Neurosci. 2004 Apr;22(2):73-86
15036382
J Neurosci. 2011 Apr 13;31(15):5865-75
21490228
Alcohol Clin Exp Res. 2002 Aug;26(8):1259-68
12198403
J Comp Neurol. 2005 Aug 29;489(3):275-92
16025454
Brain Sci. 2016 Jul 27;6(3):null
27472367
Brain Behav Immun. 2016 Jul;55:60-9
26851132
Brain Behav Immun. 2011 Jun;25 Suppl 1:S106-19
21356306
J Neurochem. 2012 Mar;120(6):948-63
22182318
Brain Behav Immun. 2011 Jun;25 Suppl 1:S146-54
21377524
J Pharmacol Exp Ther. 2010 Jan;332(1):298-307
19843974
Methods Mol Biol. 2012;829:205-30
22231816
Pharmacol Biochem Behav. 2004 Feb;77(2):405-13
14751471
J Neurochem. 2008 Jul;106(2):757-69
18419759
Eur J Pharmacol. 2003 Feb 28;463(1-3):35-53
12600701
Exp Neurol. 2008 Apr;210(2):349-58
18190912
Brain Behav Immun. 2016 Jan;51:70-91
26260453
Alcohol Clin Exp Res. 2015 Dec;39(12 ):2375-85
26556523
J Neurosci Res. 2013 Sep;91(9):1143-51
23686747
Neuropsychopharmacology. 2005 Sep;30(9):1662-9
15726114
Neuropsychopharmacology. 2008 Mar;33(4):867-76
17551540
Neuropsychopharmacology. 2015 May;40(6):1549-59
25567426
Alcohol Clin Exp Res. 2008 Aug;32(8):1350-60
18540921
J Neurodev Disord. 2013 Aug 29;5(1):22
23988237